Supreme Court Will Uphold Test Patent, Expert Predicts

Washington Drug Letter
While the U.S. Supreme Court appears unconvinced after oral arguments on Prometheus Laboratories’ thiopurine metabolites test patent, one legal expert predicts the high court will uphold an appeals court decision in favor of Prometheus.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00